期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血管紧张素Ⅱ受体拮抗剂治疗充血性心力衰竭研究进展 被引量：1

下载PDF
导出
摘要 血管紧张素 受体拮抗剂是治疗充血性心力衰竭的新型药物 ,由于其无血管紧张素 逃逸 ,且高效、低毒副作用 ,有望成为治疗充血性心力衰竭的重要药物之一。
作者 郭明 王亚 杨欣国
机构地区 武警云南总队医院 云南体委医院 第四军医大学唐都医院心内科
出处 《心脏杂志》 CAS 2002年第2期167-169,共3页 Chinese Heart Journal
关键词 血管紧张素Ⅱ受体拮抗剂 心力衰竭 充血性
分类号 R972 [医药卫生—药品] R541.61 [医药卫生—心血管疾病]
  • 相关文献

参考文献4

二级参考文献6

  • 1Kranzhofer R,Schmidt J,Pfeiffer CA,et al.Angiotensin induces inflammatory activation of human vascular smooth muscle cells[].Arteriosclerosis and Thrombosis.1999
  • 2Hocking DC,Philips PG,Ferro TJ,et al.Mechanisms of pulmonary edema induced by tumor necrosis factor-alpha[].Circulation Research.1990
  • 3Tustamoto T,Hisanaga T,Wada A,et al.Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure[].Journal of the American College of Cardiology.1998
  • 4Naftilan AJ,Pratt RE,Diau VJ.Induction of platelet derived growth factor A chain and cmyc gene expressions by angiotensin Ⅱ in cultured rat vascular smooth muscle cells[].The Journal of Clinical Investigation.1989
  • 5Hegewisch S,Weh HJ,Hossfeld DK.TNF-α induced cardiomyopathy[].The Lancet.1990
  • 6Scheidegger KJ,Butler S,Witztum JL,et al.Angiotensin Ⅱ increases macrophage-mediated modification of low density lipoprotein via a lipoxygenase-dependent pathway[].Journal of Biological Chemistry.1997

共引文献16

同被引文献12

  • 1The Digitalis Investigation Group. The effect of digoxin on mortality And morbidity in patients with heart failure[J]. N Engl J Med, 1997,336:525--533.
  • 2Moiseyev VS, Andrejevs N, Lehtonen LA, et al. The RUSSLAN Study Group. Randomized study on safety and effectiveness of levosimendan in patients with left ventricular failure after an acute myocardial hafarction[J]. J Card Fail, 1999, 5(Suppl 1) :43.
  • 3Kostis JB, Rouleau JL, Pfeffer MA, et al. Beneficial effects of vasopeptidase inhibition on mortality and morbidity in heart failure: evidence from the Omapatrilat Heart Failure Pregram[J].J Am Coll Cardiol, 2000, 35 (Suppl A) : 240A.
  • 4Franco-Cereceda A, McCarthy PM, Blackstone EH, et al. Partial left ventriculectomy for dilated cardiomyopathyz is this an alternative to transplantation? [J]. J Thorac Cardiovasc Surg,2001,121 (5): 879--893.
  • 5Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay[J]. N Engl J Med, 2001,344(12):873--880.
  • 6Packer M, Poole-Wilson P , Armstrong P,et al. Comparative effects of low and high doses of the angiotansin-converting enzyme inhibitor, lisinopril And mortality in chronic heart failure[J]. Circulation, 1999,100:1-7.
  • 7Yusuf S,Sleight P,Pogue J,et al. Effects of an angiotensin-converting enzyme, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators[J]. N Engl J Med, 2000,342(3):145--153.
  • 8Pott B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure[J]. N Engl J Med, 1999,341,709--717.
  • 9Pitt B, Segal R, Marinez FA, et al. Effects of losartan compared with captopril in patients with symptomatic heart failure:randomized trial-the Losartan Heart Failure Survival Study ELITE Ⅱ [J]. Lancet, 2000,355:1582--1587.
  • 10Cohn JN, Tognoni G. Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure[J]. N Engl J Med, 2001,345 (23):1667--1675.

引证文献1

心脏杂志
2002年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部